Viropro, Inc. (VPRO)

[Bepractical]

In his defense, PUMA does have shares they are unloading. We know the current O/S is about 920MM, authorization went up to 1.5B from 1B.

It is no secret that the company requires financing to build their CRAM model, financing/acquisitions are either cash based or through equity. Like most legitimate startups in this industry they are heavily saddled with debt in the beginning stages. I do not have a problem with this, it's how most companies in this field begin.

This is a 2 year hold, minimum, if you are expecting exponential gains near term then you are mistaken and should probably sell if you aren't comfortable.

This company is trying to position themselves in the early stages of what will be a huge transition in the pharm market place over the next few years. VIROPRO's niche is that they will be able to offer biosimilars at a significantly reduced cost compared to competitors in this space.

Look at the team that they have, they are industry leading professionals, it's not Bob the 30 year mechanic who all of a sudden heads a Mexican gold mining company. If Viropro doesn't succeed, it's not going to be because of a pump and dump with stock promotions and daily press releases with a whole lot of nothing.